Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

Led by Rep. Jen Kiggans (R-Va.), the Republicans said the tax bill included some “reasonable phase-out schedules” but that ...

In March 2025, BiomX announced positive results from the Company's DFO Adaptive Novel Care Evaluation (DANCE™) Phase 2 trial evaluating its BX211 phage treatment for DFO associated with Staphylococcus ...

ZoomInfo Technologies upgraded to Buy amid improved fundamentals, rising enterprise traction, and solid Q1 results. Read why ...

Many taxpayers could see even more money in their pockets in coming years under a sweeping tax and spending cuts package that ...

The Phase 2 study of oral, once-daily mavorixafor was a six-month, open-label clinical trial that enrolled a total of 23 ...

Integral Metals Corp. (the "Company" or "Integral") is pleased to announce that preparations are underway for the Phase 2 exploration program at its 100%-owned KAP Project in the Mackenzie Mountains, ...

Allogene Therapeutics is cutting back to stretch its cash runway into the second half of 2027, laying off 28% of its ...

Microsoft says it is laying off nearly 3% of its entire workforce. The tech giant didn’t disclose the total amount of lost ...

The next phase of the project is scheduled to begin on May 3 at Philippe Park. Volunteers are needed and encouraged to help with the work. Anyone looking for more information on the project or a ...

Explore how SiC and GaN are redefining power-supply design to meet the growing demands of AI SoCs. Large language models ...